Should You Invest in Ares Capital (ARCC) Based on Bullish Wall Street Views?
Werte in diesem Artikel
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?Before we discuss the reliability of brokerage recommendations and how to use them to your advantage, let's see what these Wall Street heavyweights think about Ares Capital (ARCC).Ares Capital currently has an average brokerage recommendation (ABR) of 1.47, on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell, etc.) made by 15 brokerage firms. An ABR of 1.47 approximates between Strong Buy and Buy.Of the 15 recommendations that derive the current ABR, 10 are Strong Buy and three are Buy. Strong Buy and Buy respectively account for 66.7% and 20% of all recommendations.Brokerage Recommendation Trends for ARCCCheck price target & stock forecast for Ares Capital here>>>The ABR suggests buying Ares Capital, but making an investment decision solely on the basis of this information might not be a good idea. According to several studies, brokerage recommendations have little to no success guiding investors to choose stocks with the most potential for price appreciation.Do you wonder why? As a result of the vested interest of brokerage firms in a stock they cover, their analysts tend to rate it with a strong positive bias. According to our research, brokerage firms assign five "Strong Buy" recommendations for every "Strong Sell" recommendation.This means that the interests of these institutions are not always aligned with those of retail investors, giving little insight into the direction of a stock's future price movement. It would therefore be best to use this information to validate your own analysis or a tool that has proven to be highly effective at predicting stock price movements.Zacks Rank, our proprietary stock rating tool with an impressive externally audited track record, categorizes stocks into five groups, ranging from Zacks Rank #1 (Strong Buy) to Zacks Rank #5 (Strong Sell), and is an effective indicator of a stock's price performance in the near future. Therefore, using the ABR to validate the Zacks Rank could be an efficient way of making a profitable investment decision.ABR Should Not Be Confused With Zacks RankIn spite of the fact that Zacks Rank and ABR both appear on a scale from 1 to 5, they are two completely different measures.Broker recommendations are the sole basis for calculating the ABR, which is typically displayed in decimals (such as 1.28). The Zacks Rank, on the other hand, is a quantitative model designed to harness the power of earnings estimate revisions. It is displayed in whole numbers -- 1 to 5.Analysts employed by brokerage firms have been and continue to be overly optimistic with their recommendations. Since the ratings issued by these analysts are more favorable than their research would support because of the vested interest of their employers, they mislead investors far more often than they guide.On the other hand, earnings estimate revisions are at the core of the Zacks Rank. And empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.Furthermore, the different grades of the Zacks Rank are applied proportionately across all stocks for which brokerage analysts provide earnings estimates for the current year. In other words, at all times, this tool maintains a balance among the five ranks it assigns.There is also a key difference between the ABR and Zacks Rank when it comes to freshness. When you look at the ABR, it may not be up-to-date. Nonetheless, since brokerage analysts constantly revise their earnings estimates to reflect changing business trends, and their actions get reflected in the Zacks Rank quickly enough, it is always timely in predicting future stock prices.Is ARCC a Good Investment?In terms of earnings estimate revisions for Ares Capital, the Zacks Consensus Estimate for the current year has remained unchanged over the past month at $2.36.Analysts' steady views regarding the company's earnings prospects, as indicated by an unchanged consensus estimate, could be a legitimate reason for the stock to perform in line with the broader market in the near term.The size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, has resulted in a Zacks Rank #3 (Hold) for Ares Capital. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>It may therefore be prudent to be a little cautious with the Buy-equivalent ABR for Ares Capital.Zacks Naming Top 10 Stocks for 2025Want to be tipped off early to our 10 top picks for the entirety of 2025?History suggests their performance could be sensational.From 2012 (when our Director of Research Sheraz Mian assumed responsibility for the portfolio) through November, 2024, the Zacks Top 10 Stocks gained +2,112.6%, more than QUADRUPLING the S&P 500’s +475.6%. Now Sheraz is combing through 4,400 companies to handpick the best 10 tickers to buy and hold in 2025. Don’t miss your chance to get in on these stocks when they’re released on January 2.Be First to New Top 10 Stocks >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Ares Capital Corporation (ARCC): Free Stock Analysis ReportTo read this article on Zacks.com click here.Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks
Ausgewählte Hebelprodukte auf Ares Capital
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Ares Capital
Der Hebel muss zwischen 2 und 20 liegen
Name | Hebel | KO | Emittent |
---|
Name | Hebel | KO | Emittent |
---|
Quelle: Zacks
Nachrichten zu Ares Capital CorpShs
Analysen zu Ares Capital CorpShs
Datum | Rating | Analyst | |
---|---|---|---|
23.08.2019 | Ares Capital Neutral | Compass Point | |
19.08.2019 | Ares Capital Outperform | BMO Capital Markets | |
21.09.2017 | Ares Capital Outperform | Oppenheimer & Co. Inc. | |
28.06.2016 | Ares Capital Neutral | National Securities | |
25.02.2016 | Ares Capital Overweight | Barclays Capital |
Datum | Rating | Analyst | |
---|---|---|---|
19.08.2019 | Ares Capital Outperform | BMO Capital Markets | |
21.09.2017 | Ares Capital Outperform | Oppenheimer & Co. Inc. | |
25.02.2016 | Ares Capital Overweight | Barclays Capital | |
30.09.2015 | Ares Capital Buy | D.A. Davidson & Co. | |
13.02.2015 | Ares Capital Market Perform | BMO Capital Markets |
Datum | Rating | Analyst | |
---|---|---|---|
23.08.2019 | Ares Capital Neutral | Compass Point | |
28.06.2016 | Ares Capital Neutral | National Securities | |
05.05.2015 | Ares Capital Hold | BB&T Capital Markets | |
20.08.2009 | Allied Capital market perform | Keefe, Bruyette & Woods, Inc. | |
06.02.2007 | Update Allied Capital Corp.: Hold | AG Edwards |
Datum | Rating | Analyst | |
---|---|---|---|
06.12.2005 | Update Allied Capital Corp.: Underperform | Harris Nesbitt |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Ares Capital CorpShs nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen